In this review, we will describe the rationale of combining radiotherapy with epidermal growth factor receptor (EGFR) targeting and immunotherapy in locally advanced HNSCC (LA-HNSCC) or recurrent/metastatic HNSCC, together with clinical advances in novel treatment regimen. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.